Medigard Ltd (MGZ)

MGZ Chart

vs Index S&P/ASX 20 S&P/ASX 50 S&P/ASX 100 S&P/ASX 200 S&P/ASX 300 All Ordinaries Small Ordinaries All Technology Consumer Staples Energy Financials Health Care Industrials Info Technology Materials Real Estate Comm. Services Utilities

Advanced

Show News Mov Avgs 9-day 10-day 20-day 30-day 50-day 100-day 150-day 200-day Mov Avgs 9-day 21-day 30-day 200-day Simple Exponential Weighted Simple Exponential Weighted vs Index S&P/ASX 20 S&P/ASX 50 S&P/ASX 100 S&P/ASX 200 S&P/ASX 300 All Ordinaries Small Ordinaries All Technology Consumer Staples Energy Financials Health Care Industrials Info Technology Materials Real Estate Comm. Services Utilities

Mov Avgs 10-day 20-day 30-day 50-day 100-day 150-day 200-day 9/21 Cross 10/30 Cross Golden Cross Vol RSI BB

Day 3m 6m 1yr 5yr 10yr

MGZ's Principal Activity is the medical technologies innovation and research and development; acquisition of a licence to utilise intellectual property to advance the KT009 project to treat degenerative disk disease with an injectable product; progressing and maintenance of patents and conduct of our licence arrangement and liaison with Shanghai Sol-Millennium Medical Products Co., Ltd on the Blood Collection Device and the Flash Back Needle. The licence was terminated after the end of the financial year.

Announcements

Company Overview

Dividend History

Directors & Management

Name	Title	Since	Bio
Dr Ian Edward Dixon	Executive Director	Nov 2017	Dr Ian Edward Dixon Executive Director Dr Dixon is a Managing Director and owner of Altnia Group, a biotechnology company with a portfolio of human therapeutic products and technologies. Dr Dixon is a co-inventor of a number of technologies and was the head of the Invetech Product Group, a leading medical device development business. Dr Dixon has direct experience in product innovation, technology commercialisation, partnering and capital raising.
Mr Craig Duncan Cameron	Non-Executive Director	Nov 2016	Mr Craig Duncan Cameron Non-Executive Director Mr Cameron has almost 30 years' CEO and board experience in a broad range of industries working in the USA, Canada, Japan, Australia, New Zealand and the UK running start-ups, turnarounds and mature businesses in IT services, nutraceuticals, information technology, communications, healthcare, green tech and clean technology industries.
Dr Christopher Jan Bishop	Non-Executive Director,Non-Executive Chairman	Sep 2008	Dr Christopher Jan Bishop Non-Executive Director,Non-Executive Chairman Dr Bishop has experience in the development and manufacture of sophisticated electronic products including medical instruments.
Ms Patricia Mary Boero	Chief Financial Officer,Alternate Director - Donald Channer,Company Secretary	Mar 2006	Ms Patricia Mary Boero Chief Financial Officer,Alternate Director - Donald Channer,Company Secretary Ms Boero has experience in accounting and financial services across a broad range of industries.
Mr Donald Julian Channer	Non-Executive Director	Oct 1999	Mr Donald Julian Channer Non-Executive Director Mr Channer served as Chairman of the Company from incorporation until 20 October 2017. He has been involved in many private companies as both director and chairman.

Show All

Director Transactions

Date	Director	Type	Amount	Price	Value	Notes
09/12/19	Christopher Bishop	Issued	1,818,570	$0.014	$25,460	Issue of securities
09/12/19	Craig Cameron	Issued	1,454,856	$0.014	$20,368	Issue of securities
09/12/19	Donald Channer	Issued	7,142,857	$0.014	$100,000	Issue of securities
09/12/19	Ian Dixon	Issued	14,608,569	$0.014	$204,520	Issue of securities
09/12/19	Donald Channer	Issued	7,142,857	$0.014	$100,000	Issue of securities
31/07/18	Christopher Bishop	Issued	3,714,285	$0.018	$65,000	Placement
31/07/18	Patricia Boero	Issued	1,428,571	$0.018	$25,000	Placement
31/07/18	Donald Channer	Issued	3,428,571	$0.018	$60,000	Placement
31/07/18	Ian Dixon	Issued	1,428,571	$0.018	$25,000	Placement
31/07/18	Ian Dixon	Issued	80,000,000	$0.016	$1,280,000	Issue of options

Show All

Director Interests

Director	Last Notice	Direct Shares	Indirect Shares	Options	Convertibles
Christopher Bishop	09/12/2019	283,334	7,032,855	N/A	N/A
Craig Cameron	09/12/2019	N/A	2,454,856	N/A	N/A
Donald Channer	09/12/2019	37,689,120	11,708,861	N/A	N/A
Ian Dixon	09/12/2019	N/A	16,037,140	80,000,000	N/A
Patricia Boero	29/08/2019	725,829	4,978,571	N/A	N/A

Show All

Top 20 Shareholders About the Data

Name	Shares	Capital
Donald Julian Channer	30,546,263	22.58%
Robin J Bishop & Christopher J Bishop <Bishop Family Super Fund A/C>	5,214,285	3.85%
Sun Sea Pty Ltd	4,566,004	3.37%
Mr Warner Lamb & Mrs Aily Lamb <Lamb Superfund A/C>	4,200,000	3.10%
Ganbaru Pty Ltd <The Parrish Super Fund A/C>	3,767,004	2.78%
Allop Pty Ltd <Alan Porter Family A/C>	3,607,143	2.67%
Woodwright Services Pty Ltd <PMB Family A/C>	3,500,000	2.59%
Mr Robert William Higham & Mrs Rhonda Catherine Higham <Higham Family S/F A/C>	3,200,000	2.37%
Montezuma Pty Ltd <Prometheus A/C>	2,857,143	2.11%
Mr Richard Lutkajtis <Richards Roofing Service A/C>	2,127,734	1.57%
RHC Superfund Pty Ltd <RHC Superannuation Fund A/C>	1,553,575	1.15%
Mr Robert Krakowiak	1,500,000	1.11%
3DI Design Pty Ltd <Aarc Investment A/C>	1,500,000	1.11%
Helium Management Pty Ltd <Helium Super Fund A/C>	1,428,571	1.06%
Joanne Hook	1,428,571	1.06%
Mrs Patricia Mary Boero & Mr John Anthony Boero <PMB Superannuation Fund A/C>	1,428,571	1.06%
Mr Matthew Simon Anthony Kelly	1,400,000	1.03%
Mr Gary Brian Stone & Mrs Janis Ann Stone	1,370,000	1.01%
Mr Philip Bickley Callard	1,295,684	0.96%
Mr Joel David Webb	1,200,000	0.89%

Show All

Shareholder Distribution

As reported in the most recent Annual Report.

The most recent Annual Report didn't contain Shareholder Distribution data.

Substantial Shareholders

Shareholders Buying

12 month transaction history compiled from ASX announcements.

No buy transactions reported by Substantial Shareholders in the past 12 months.

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Share Price History

Date	Close	Change	%Chg	Open	High	Low	Volume	Turnover

Full Month

Historical Data

Year	Closing Price	Last Trade
2020	$0.02	30 June
2019	$0.02	28 June
2018	$0.016	29 June
2017	$0.011	28 June
2016	$0.038	28 June
2015	$0.075	30 June
2014	$0.023	30 June

MGZ Historical Price Data (CSV)

Up to 20 years of EOD share price history

Sign up to Download

You must be logged in to access this feature. Please sign up for free or login.